ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OCGN Ocugen Inc

1.18
0.00 (0.00%)
Pre Market
Last Updated: 04:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Ocugen Inc OCGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 1.18 04:00:00
Open Price Low Price High Price Close Price Prev Close
1.18
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/19/202407:13GLOBEOcugen Announces Dosing Completion of Subjects with..
4/12/202407:30GLOBEOcugen to Participate in Fireside Chat at the Emerging..
4/10/202407:02GLOBEOcugen, Inc. Announces Positive Scientific Advice from the..
4/08/202406:30GLOBEOcugen, Inc. Announces U.S. FDA Clearance of IND Amendment..
4/05/202407:02GLOBEOcugen Announces Positive Data and Safety Monitoring Board..
4/02/202408:00GLOBEOcugen Provides Business Update with Certain Financials for..
4/01/202418:08GLOBEOcugen Announces Positive Data and Safety Monitoring Board..
4/01/202417:43GLOBEOcugen to Host Conference Call on Tuesday, April 2 at 8:30..
3/18/202406:30GLOBEOcugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical..
3/13/202408:00GLOBEOcugen, Inc. Announces Dosing Completion of Subjects with..
3/06/202407:30GLOBEOcugen to Present at Investing in Cures Summit
2/28/202408:00GLOBEOcugen Clinical Showcase Webcast Now Available
2/26/202408:30GLOBEOcugen Chairman and CEO to present at Abu Dhabi Family..
2/22/202416:05GLOBEOcugen, Inc. Announces Dosing Completion of Subjects with..
2/21/202416:05GLOBEOcugen to Present at 2024 BIO CEO & Investor Conference
2/21/202411:22EDGAR2Form 8-K - Current report
2/14/202407:30GLOBEOcugen to Host Clinical Showcase in New York City..
1/31/202408:00GLOBEOcugen to Present at Pharma Market Research Conference
1/16/202407:30GLOBEOcugen, Inc. Announces Bob Smith Joins Business Advisory..
1/08/202406:05EDGAR2Form 8-K - Current report
1/05/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202315:09EDGAR2Form 8-K - Current report
12/21/202306:30GLOBEOcugen Gains FDA Alignment on Key Aspects of OCU400—Modifier..
12/19/202307:30GLOBEOcugen Announces OCU400 Receives Regenerative Medicine..
12/13/202307:30GLOBEOcugen, Inc. Announces First Patient Dosed in Phase 1/2..
11/29/202307:30GLOBEOcugen CEO to Present at NobleCon19 – Noble Capital Markets’..
11/10/202307:30GLOBEOcugen, Inc. Announces First Patient Dosed in Phase 1/2..
11/09/202308:02EDGAR2Form 8-K - Current report
11/09/202307:02EDGAR2Form 8-K - Current report
11/09/202306:30GLOBEOcugen Provides Business Update with Third Quarter 2023..
11/09/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202307:45GLOBEOcugen CSO to Participate in 4th Annual Dry AMD Therapeutic..
11/02/202307:30GLOBEOcugen to Host Conference Call on Thursday, November 9 at..
10/10/202309:05EDGAR2Form 8-K - Current report
10/10/202306:30GLOBEOcugen Mucosal Vaccine Candidate OCU500 Selected by..
10/04/202307:00GLOBEOcugen to Present at the 2023 Cell & Gene Meeting on the..
9/29/202307:30GLOBEOcugen CSO to Participate in 4th Annual Gene Therapy for..
9/27/202319:30GLOBEOcugen to Participate in Fireside Chat at Chardan’s 7th..
9/21/202307:30GLOBEOcugen, Inc. Announces Connie Collingsworth Joins Business..
9/20/202308:00GLOBEOcugen to Participate in Panel at Cantor Fitzgerald Global..
9/19/202316:54EDGAR2Form 8-K - Current report
9/19/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/13/202308:28EDGAR2Form 8-K - Current report
9/13/202308:15GLOBEOcugen Announces Positive Clinical Study Update from the..
9/12/202319:30GLOBEOcugen to Host Virtual Investor & Analyst Event on September..
8/22/202309:12EDGAR2Form 8-K - Current report
8/21/202316:48EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock